−0.010 CAD
−1.22 M CAD
17.82 M CAD
126.99 M
About DEVONIAN HEALTH GROUP INC
Sector
CEO
Luc D. Grégoire
Headquarters
Montmagny
Website
Founded
2015
FIGI
BBG006BRCGL2
Devonian Health Group, Inc. is a pharmaceutical company, which engages in the development of botanical drugs. It also involved in the development of value-added products for dermo-cosmetics and the distribution of pharmaceutical products. The company was founded by Andre P. Boulet on March 27, 2015 and is headquartered in Montmagny, Canada.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of GSD is 0.190 CAD — it has increased by 2.70% in the past 24 hours. Watch DEVONIAN HEALTH GROUP INC stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on TSXV exchange DEVONIAN HEALTH GROUP INC stocks are traded under the ticker GSD.
GSD stock has fallen by −20.83% compared to the previous week, the month change is a 52.00% rise, over the last year DEVONIAN HEALTH GROUP INC has showed a 22.58% increase.
GSD stock is 5.56% volatile and has beta coefficient of 2.60. Track DEVONIAN HEALTH GROUP INC stock price on the chart and check out the list of the most volatile stocks — is DEVONIAN HEALTH GROUP INC there?
Today DEVONIAN HEALTH GROUP INC has the market capitalization of 31.13 M, it has increased by 11.36% over the last week.
Yes, you can track DEVONIAN HEALTH GROUP INC financials in yearly and quarterly reports right on TradingView.
GSD net income for the last quarter is 1.08 M CAD, while the quarter before that showed −373.82 K CAD of net income which accounts for 389.16% change. Track more DEVONIAN HEALTH GROUP INC financial stats to get the full picture.
No, GSD doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Dec 22, 2024, the company has 8.00 employees. See our rating of the largest employees — is DEVONIAN HEALTH GROUP INC on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. DEVONIAN HEALTH GROUP INC EBITDA is −185.61 K CAD, and current EBITDA margin is −1.04%. See more stats in DEVONIAN HEALTH GROUP INC financial statements.
Like other stocks, GSD shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade DEVONIAN HEALTH GROUP INC stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So DEVONIAN HEALTH GROUP INC technincal analysis shows the buy rating today, and its 1 week rating is neutral. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating DEVONIAN HEALTH GROUP INC stock shows the neutral signal. See more of DEVONIAN HEALTH GROUP INC technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.